All News

New studies say yes.

Three successful pharmacy owners tell us how it's done.

The product-tracing deadline has been extended to November 1. Other requirements are on schedule. Here's what you have to do, and when you have to do it.

What does birth control have to do with medication adherence? David Stanley connects the dots.

Confronted by overwhelming workplace challenges, pharmacists sometimes forget they have options. It's time to step outside the limits of habitual thinking and take a look around.

Sterile compounders have voluntarily undertaken several upgrades to their processes and products. The results benefit patients, pharmacists, and the profession overall.

R&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.

Some tips on making community connections

A look at some of the year's launches from key manufacturers.

Letters, e-mails, posts, and comments from Drug Topics readers

Some OTC products designed to keep those summer adventures fun

New Rx, generics, and OTC

Community pharms discuss competitive options at McKesson's ideaShare.

Researchers plan to study the best way to deploy pharmacy-based naloxone rescue kits to help prevent opioid overdoses and deaths.

The owner of a Los Angeles pharmacy was recently sentenced to 18 months in prison after pleading guilty to charges he participated in a fraud scheme involving the Medicare Part D prescription drug program.

Beginning next year, CVS/Caremark will no longer provide insurance coverage for the erectile dysfunction drug Viagra.

When people are injured by pharmacy mistakes, it is a public safety issue. Where are the state boards of pharmacy?

CVS Health reported a strong second quarter in 2015 with overall net revenue up 7.4% to $37.2 million, compared to the same period last year.

CVS Health is partnering with IBM to document and analyze patient behaviors so that pharmacists and other healthcare professionals can better manage chronic illnesses.

Pharmacists working in healthcare teams were able to better control blood pressure in patients with uncontrolled hypertension, according to a recent study.

Two patients taking the multiple sclerosis drug fingolimod (Gilenya) developed progressive multifocal leukoencephalopathy (PML), a rare and serious brain infection, FDA reported.

Results from the REVERSE-AD prospective cohort study.

FDA issued a drug safety warning that there have been 50 reports of medication errors because of confusion between the antidepressant Brintellix (vortioxetine) and the antiplatelet agent Brilinta (ticagrelor).

Many people are pondering that question following the recent release of statistics from the Drug Enforcement Administration that showed Indiana led the nation in pharmacy robberies.

The Drug Enforcement Administration recently announced plans to hold its 10th National Prescription Drug Take-Back on September 26, 2015.

Pharmacogenomics has the potential to save the U.S. healthcare industry $136 billion in adverse drug events and serve as a profit center for community pharmacies.

That’s the allegation made in a potential class action lawsuit that claims CVS deliberately overcharged some customers for generic drugs by submitting claims to their insurance companies at inflated prices.

The U.S. Court of Appeals for the Federal Circuit in Washington has ruled that Novartis AG’s Sandoz may begin selling the first copy of Amgen Inc.’s Neupogen as soon as Sept. 2.